Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of British Columbia

$105,000.00

Regulation of microRNA expression by interleukin-10 in activated macrophages

EF 2010-11

Résumé
Inflammation is a protective response against infection but it must be appropriately controlled and terminated to avoid pathological consequences. A key anti-inflammatory regulator of immune cells is a cytokine (a type of hormone) called interleukin-10 (IL-10). The importance of IL-10 in regulating immune cell function is illustrated by the fact that many tumour cells and intracellular pathogens produce or elicit production of IL-10 to enhance their survival. Thus, understanding the mechanism by which IL-10 regulates the network of intracellular signal transduction pathways will not only provide insight into development of therapeutics mimicking the beneficial, anti-inflammatory effects of IL-10, it will also allow development of strategies to counter the immunosuppressive effects of certain tumours and immune cell pathogens. Recent research shows that IL-10 may, in part, regulate immune cell function through altering the amount of small RNAs (microRNAs, abbreviated miRNA) found in cells. There are approximately 1000 different miRNAs in the mammalian genome, each of which controls a specific network of genes. Stimulation of immune cells such as the macrophage with bacteria (or with substances found on the surface of bacteria) leads to changes in the levels of certain miRNAs. We have found that IL-10 counteracts some of these changes, and may indeed induce some specific changes that are important in IL-10 inhibition of cell activation. One miRNA of particular interest is miR-155. We now propose i) to continue to investigate how IL-10 regulates miR-155 levels, ii) to systematically identify all the miRNAs whose levels change in cells treated with IL-10, and iii) to determine the contribution of each miRNA to the ability of IL-10 to inhibit inflammation. These studies will lead to a better understanding of how IL-10 works and the knowledge can be used to develop miRNA-based therapeutic strategies to mimic or inhibit IL-10 action when needed.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
229568
Name
Cheung Tsz Ying Sylvia
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Regulation of microRNA expression by interleukin-10 in activated macrophages
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Cytokines; Immunology; Immunoregulation; Inflammation; Macrophages; Micrornas; Protein Purification; Real-Time Pcr; Signal Transduction; Transplantation
Abstract
Inflammation is a protective response against infection but it must be appropriately controlled and terminated to avoid pathological consequences. A key anti-inflammatory regulator of immune cells is a cytokine (a type of hormone) called interleukin-10 (IL-10). The importance of IL-10 in regulating immune cell function is illustrated by the fact that many tumour cells and intracellular pathogens produce or elicit production of IL-10 to enhance their survival. Thus, understanding the mechanism by which IL-10 regulates the network of intracellular signal transduction pathways will not only provide insight into development of therapeutics mimicking the beneficial, anti-inflammatory effects of IL-10, it will also allow development of strategies to counter the immunosuppressive effects of certain tumours and immune cell pathogens. Recent research shows that IL-10 may, in part, regulate immune cell function through altering the amount of small RNAs (microRNAs, abbreviated miRNA) found in cells. There are approximately 1000 different miRNAs in the mammalian genome, each of which controls a specific network of genes. Stimulation of immune cells such as the macrophage with bacteria (or with substances found on the surface of bacteria) leads to changes in the levels of certain miRNAs. We have found that IL-10 counteracts some of these changes, and may indeed induce some specific changes that are important in IL-10 inhibition of cell activation. One miRNA of particular interest is miR-155. We now propose i) to continue to investigate how IL-10 regulates miR-155 levels, ii) to systematically identify all the miRNAs whose levels change in cells treated with IL-10, and iii) to determine the contribution of each miRNA to the ability of IL-10 to inhibit inflammation. These studies will lead to a better understanding of how IL-10 works and the knowledge can be used to develop miRNA-based therapeutic strategies to mimic or inhibit IL-10 action when needed.
Competitiondate
201010
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Cheung, Tsz Ying Sylvia
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~